Prognostic Value of Hematological Parameters in Oral Squamous Cell Carcinoma
Cancers · 31.10.2023 · 15 (21) · 5245
DOI: 10.3390/cancers15215245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 31.10.2023. Verfasst von Lorenzo Fernandes Moça Trevisani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação em Anestesiologia, Ciências Cirúrgicas e Medicina Perioperatória, Faculdade de Medicina, Universidade de São Paulo, São Pau…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, National Council for Scientific and Technological Development, Fundação de Amparo à Pesquisa do Estado de São Paulo—FAPESP.
Abstract (Originalsprache)
Introduction
Oral squamous cell carcinoma (OSCC) remains a significant public health concern. The variables utilized to determine appropriate treatment for this disease also represent its most unfavorable prognostic factors, with these parameters solely determined by the neoplasm and its behavior. However, a lack of well-established indices is evident in the literature that specifically relate to the patient and indicate a worse prognosis.
Objective
To assess the prognostic impact of hematological indices in patients with OSCC.
Methods
This retrospective cohort study included patients with oral squamous cell carcinoma (OSCC) who underwent curative-intent treatment. Treatment encompassed surgery, followed by adjuvant therapy, as necessary. Laboratory tests were conducted immediately prior to surgery, and demographic information was obtained from medical records.
Results
The cohort comprised 600 patients, with 73.5% being male subjects. Adjuvant treatment was recommended for 60.3% of patients. Throughout the follow-up period, 48.8% of participants died. Univariate analysis indicated that perineural invasion, angiolymphatic invasion, pT4 tumors, lymph node metastases, extranodal extravasation, RDW > 14.3%, NLR (neutrophil–lymphocyte ratio) > 3.38, PLR (platelet–lymphocyte ratio) > 167.3, and SII (systemic inflammatory/immune response index) > 416.1 were factors associated with increased mortality. These threshold values were established through ROC curve analysis. In the multivariate analysis, angiolymphatic invasion (HR = 1.43; 95% CI: 1.076–1.925; p = 0.014), pT4a/b tumors (HR = 1.761; 95% CI: 1.327–2.337; p < 0.001), extranodal extravasation (HR = 1.420; 95% CI: 1.047–1.926; p = 0.024), and RDW (HR = 1.541; 95% CI: 1.153–2.056; p = 0.003) were identified as independent risk factors for decreased overall survival.
Conclusions
RDW > 14.3% was proven to be a reliable parameter for assessing overall survival in patients with OSCC. Further studies are required to evaluate the clinical applicability of other hematological indices.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Programa de Pós-Graduação em Anestesiologia, Ciências Cirúrgicas e Medicina Perioperatória, Faculdade de Medicina, Universidade de São Paulo, São Paulo 01246-903, Brazil.
- Instituto do Câncer do Estado de São Paulo (Icesp), Faculdade de Medicina, Universidade de São Paulo, São Paulo 01246-000, Brazil.
- Head and Neck Surgery Department, Instituto do Câncer do Estado de São Paulo (Icesp), Faculdade de Medicina, Universidade de São Paulo, São Paulo 01246-000, Brazil.
- Head and Neck Surgery Department, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo 01246-000, Brazil.
- Head and Neck Surgery Department, Faculdade de Medicina, Universidade de São Paulo, São Paulo 01246-000, Brazil.
- Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo 05652-000, Brazil.
ORCID-Profile: Rogerio Aparecido Dedivitis, Leandro Luongo Matos
Förderung
- São Paulo Research Foundation
- National Council for Scientific and Technological Development
- Fundação de Amparo à Pesquisa do Estado de São Paulo—FAPESP
- Conselho Nacional de Desenvolvimento Científico e Tecnológico—CNPq
Zitieren
APA
Trevisani, L. F. M., Kulcsar, I. F., Kulcsar, M. A. V., Dedivitis, R. A., Kowalski, L. P., & Matos, L. L. (2023). Prognostic Value of Hematological Parameters in Oral Squamous Cell Carcinoma. Cancers, 15(21), 5245. https://doi.org/10.3390/cancers15215245
Vancouver
Trevisani LFM, Kulcsar IF, Kulcsar MAV, Dedivitis RA, Kowalski LP, Matos LL. Prognostic Value of Hematological Parameters in Oral Squamous Cell Carcinoma. Cancers. 2023;15(21):5245. doi:10.3390/cancers15215245
BibTeX
@article{Trevisani2023,
author = {Trevisani, Lorenzo Fernandes Moça and Kulcsar, Isabelle Fernandes and Kulcsar, Marco Aurélio Vamondes and Dedivitis, Rogerio Aparecido and Kowalski, Luiz Paulo and Matos, Leandro Luongo},
title = {Prognostic Value of Hematological Parameters in Oral Squamous Cell Carcinoma},
journal = {Cancers},
year = {2023},
volume = {15},
number = {21},
pages = {5245},
doi = {10.3390/cancers15215245}
}
EUVIMED